標的型薬剤投与および増強がん免疫療法のための感受性マスト細胞
Yan Xu1, Xiaoge Zhang1, Xiao Han2
1State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang Provincial Key Laboratory for Advanced Drug Delivery Systems, School of Pharmacy, Zhejiang University, Hangzhou 310058, Zhejiang, China; Liangzhu Laboratory, Zhejiang University, Hangzhou 311121, Zhejiang, China.
Cell
|December 10, 2025
まとめ
エンジニアリングされたマスト細胞は がん治療のために腫瘍に 腫瘍性ウイルスを送り込みます このアプローチは 腫瘍の抗原を駆使して 発症を誘導し 局所免疫を活性化し 腫瘍の成長を抑制し 免疫療法に希望を示しています
科学分野:
- 免疫学
- 腫瘍学
- バイオテクノロジー
背景:
- 細胞媒介による薬剤投与は,がん治療の有効性を高めることを示しています.
- 腫瘍への治療薬の標的型投与は依然として課題です
研究 の 目的:
- 免疫グロブリンE (IgE) 感受性マスト細胞 (IgE-MCs) を,抗原誘導による腫瘍性アデノウイルス (OVs) の投与のために設計する.
- 局所的な免疫活性化と腫瘍の微小環境の改造のためのIgE-MCの可能性を評価する.
- 臨床前がんモデルにおけるIgE-MC媒介によるOV投与の治療効果を評価する.
主な方法:
- 腫瘍特異性抗原を認識するIgE-MCを設計する
- IgE-MCを腫瘍性アデノウイルス (OV) に負荷する.
- HER2陽性患者からの異種移植モデルを含むネズミのモデルにおける腫瘍の蓄積,免疫活性化,および腫瘍成長抑制の評価.
主要な成果:
- 抗原陽性腫瘍にIgE-MCが蓄積され,標的型OVの投与が容易になりました.
- エンジニアリングされたマスト細胞は ケモカインと炎症媒体を放出し 腫瘍の微小環境を再構成します
- IgE- MCで封じ込められたOVは,強力な抗がん免疫反応を誘発し,複数のモデルで腫瘍の成長を抑制しました.
- 人間化されたモデルでは,抗HER2IgEとOVを搭載したヒトMCは,腫瘍内T細胞の反応を高め,腫瘍の成長を減少させた.
結論:
- IgE-MCは,腫瘍性アデノウイルスを発達させるための効果的な抗原特異性プラットフォームとして機能する.
- このアプローチは局所的な免疫活性化を促進し,がんの免疫療法を強化するために腫瘍の微小環境を修正します.
- この研究は,臨床的に重要な環境におけるIgE- MCの翻訳的可能性を示し,標的がん治療のための患者特有のIgE選択をサポートしています.
関連する概念動画
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer Vaccines
929
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
929
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K


